Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2024	Dec. 31, 2023
Operating activities
Net increase (decrease) in net assets resulting from operations	$ 473,034	$ 45,354,002	$ 28,258,219
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net realized (gain) loss	0	1,431,808	(77,570)
Change in net unrealized (appreciation) depreciation of investments	3,349,572	(3,345,673)	(5,346,656)
Net amortization of investment discounts and premiums	(526,436)	(5,020,865)	(3,167,347)
Interest and dividend income paid in kind	(128,409)	(1,375,308)	(694,111)
Amortization of deferred debt issuance costs	109,094	438,149	193,554
Changes in assets and liabilities:
Purchases of investments	(217,342,907)	(773,893,941)	(248,934,358)
Proceeds from disposition of investments	7,093,801	142,736,794	64,848,048
Decrease (increase) in interest, dividends and fees receivable	(1,265,323)	(3,124,063)	(2,134,446)
Decrease (increase) in receivable for investments sold	(22,548)	(7,377,342)	(596,291)
Decrease (increase) in prepaid expenses and other assets	(283,390)	(1,541,422)	(489,986)
Increase (decrease) in interest and debt related payables	1,090,190	1,843,476	1,075,837
Increase (decrease) in incentive fees payable	0	3,978,275	0
Increase (decrease) in management fees payable	0	1,791,192	0
Increase (decrease) in accrued capital gains incentive fees	0	498,552	0
Increase (decrease) in reimbursements due to the Investment Adviser	48,566	877,413	199,376
Increase (decrease) in payable for investments purchased	7,174,463	29,486,011	6,686,087
Increase (decrease) in accrued expenses and other liabilities	1,149,618	6,822	214,362
Net cash provided by (used in) operating activities	(199,080,675)	(567,236,120)	(159,965,282)
Financing activities
Proceeds from common shares sold	118,655,300	373,956,051	91,787,065
Contribution received in advance	4,950,000	0	11,924,839
Proceeds from issuance of Tranche A Notes	0	70,000,000	0
Draws on credit facilities	135,000,000	396,000,000	121,000,000
Repayments of credit facility draws	(40,000,000)	(232,000,000)	(60,000,000)
Payments of debt issuance costs	(1,888,726)	(3,546,409)	(320,295)
Dividends paid in cash to shareholders	(2,170)	(12,845,227)	(1,666,198)
Payments of repurchased shares	0	(3,643,716)	0
Net cash provided by (used in) financing activities	216,714,404	587,920,699	162,725,411
Net increase (decrease) in cash and cash equivalents (including restricted cash)	17,633,729	20,684,579	2,760,129
Cash and cash equivalents (including restricted cash) at beginning of period	0	20,393,858	17,633,729
Cash and cash equivalents (including restricted cash) at end of period	17,633,729	41,078,437	20,393,858
Supplemental cash flow information
Interest payments	1,064,214	13,396,545	7,128,811
Excise tax payments	0	0	18,395
Distribution payable	1,440,887	6,009,553	3,651,224
Reinvestment of dividends during the period	$ 1,819,100	$ 31,610,193	$ 17,295,327